This inventor holds 1 USPTO granted patent. Top assignees: Dongguk University Industry-Academic Cooperation Foundation, Korea Institute of Science and Technology, Snu Rdb Foundation. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2017
Title: The Innovations of In Cheol Sun: Pioneering CT Contrast Medium for Thrombus Detection
Introduction: In Cheol Sun is an innovative inventor based in Seoul, South Korea, known for his significant contributions to medical imaging technologies. With a focus on enhancing the diagnosis of thrombus-related conditions, Sun has developed a unique CT contrast medium that represents a milestone in the field of cardio-cerebral vascular thrombosis. His groundbreaking work includes one patented invention that is poised to improve healthcare outcomes through advanced imaging techniques.
Latest Patents: In Cheol Sun's most notable patent is titled "CT contrast medium for detecting thrombus, comprising fibrin-targeted peptide sequence-conjugated glycol chitosan-gold nanoparticles." This invention addresses the critical need for effective thrombus detection by providing a CT contrast agent that enables rapid and repeated acquisition of detailed imaging information. The agent is particularly designed to assess the size and location of a thrombus, significantly aiding in the diagnosis and monitoring of cerebral thrombus conditions.
Career Highlights: In Cheol Sun has made substantial advancements in the field of medical research and innovation. His work has been recognized for its potential to enhance the diagnostic capabilities related to thrombotic conditions, marking him as a key figure in the intersection of technology and medicine. His achievements are a testament to his dedication to improving patient outcomes through innovative solutions.
Collaborations: Throughout his career, In Cheol Sun has collaborated with esteemed institutions, including the Dongguk University Industry-Academic Cooperation Foundation and Snur & Db Foundation. These partnerships have facilitated his research and development efforts, allowing him to push the boundaries of medical imaging technology. He has also worked alongside notable colleagues such as Dong Eog Kim and Jeong Yeon Kim, contributing to a collaborative environment that fosters innovation.
Conclusion: In Cheol Sun stands as an influential inventor, whose work with CT contrast mediums has the potential to revolutionize the detection of thrombus in patients. His dedication to advancing medical imaging, combined with his innovative spirit, positions him as a leading figure in the medical research community. As his career progresses, In Cheol Sun is likely to continue making impactful contributions to both technology and healthcare, improving diagnostic processes and patient care globally.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile